Literature DB >> 28846133

Is Alzheimer's Prevention Possible Today?

Richard Isaacson1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28846133      PMCID: PMC5710839          DOI: 10.1111/jgs.15060

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  11 in total

1.  Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts.

Authors:  A David Smith; Kristine Yaffe
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Alzheimer's Prevention Education: If We Build It, Will They Come? www.AlzU.org.

Authors:  R S Isaacson; N Haynes; A Seifan; D Larsen; S Christiansen; J C Berger; J E Safdieh; A M Lunde; A Luo; M Kramps; M McInnis; C N Ochner
Journal:  J Prev Alzheimers Dis       Date:  2014

3.  The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.

Authors:  A Seifan; R Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2015-10-01

Review 4.  The projected effect of risk factor reduction on Alzheimer's disease prevalence.

Authors:  Deborah E Barnes; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2011-07-19       Impact factor: 44.182

5.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

Authors:  Tiia Ngandu; Jenni Lehtisalo; Alina Solomon; Esko Levälahti; Satu Ahtiluoto; Riitta Antikainen; Lars Bäckman; Tuomo Hänninen; Antti Jula; Tiina Laatikainen; Jaana Lindström; Francesca Mangialasche; Teemu Paajanen; Satu Pajala; Markku Peltonen; Rainer Rauramaa; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Hilkka Soininen; Miia Kivipelto
Journal:  Lancet       Date:  2015-03-12       Impact factor: 79.321

6.  MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.

Authors:  B Vellas; I Carrie; S Gillette-Guyonnet; J Touchon; T Dantoine; J F Dartigues; M N Cuffi; S Bordes; Y Gasnier; P Robert; L Bories; O Rouaud; F Desclaux; K Sudres; M Bonnefoy; A Pesce; C Dufouil; S Lehericy; M Chupin; J F Mangin; P Payoux; D Adel; P Legrand; D Catheline; C Kanony; M Zaim; L Molinier; N Costa; J Delrieu; T Voisin; C Faisant; F Lala; F Nourhashémi; Y Rolland; G Abellan Van Kan; C Dupuy; C Cantet; P Cestac; S Belleville; S Willis; M Cesari; M W Weiner; M E Soto; P J Ousset; S Andrieu
Journal:  J Prev Alzheimers Dis       Date:  2014-06

7.  Prevention of Alzheimer's Disease: Lessons Learned and Applied.

Authors:  James E Galvin
Journal:  J Am Geriatr Soc       Date:  2017-08-02       Impact factor: 5.562

Review 8.  How well does "evidence-based" medicine help neurologists care for individual patients?

Authors:  Louis R Caplan
Journal:  Rev Neurol Dis       Date:  2007

9.  Reducing Risk of Dementia in Older Age.

Authors:  Behnam Sabayan; Farzaneh Sorond
Journal:  JAMA       Date:  2017-05-16       Impact factor: 157.335

10.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

View more
  6 in total

Review 1.  Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives.

Authors:  Teresa Pardo-Moreno; Anabel González-Acedo; Antonio Rivas-Domínguez; Victoria García-Morales; Francisco Jose García-Cozar; Juan Jose Ramos-Rodríguez; Lucía Melguizo-Rodríguez
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

Review 2.  Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention.

Authors:  Matthew W Schelke; Peter Attia; Daniel J Palenchar; Bob Kaplan; Monica Mureb; Christine A Ganzer; Olivia Scheyer; Aneela Rahman; Robert Kachko; Robert Krikorian; Lisa Mosconi; Richard S Isaacson
Journal:  Front Aging Neurosci       Date:  2018-04-10       Impact factor: 5.750

3.  The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.

Authors:  Richard S Isaacson; Christine A Ganzer; Hollie Hristov; Katherine Hackett; Emily Caesar; Randy Cohen; Robert Kachko; Josefina Meléndez-Cabrero; Aneela Rahman; Olivia Scheyer; Mu Ji Hwang; Cara Berkowitz; Suzanne Hendrix; Monica Mureb; Matthew W Schelke; Lisa Mosconi; Alon Seifan; Robert Krikorian
Journal:  Alzheimers Dement       Date:  2018-11-13       Impact factor: 21.566

4.  Alzheimer's "Prevention" vs. "Risk Reduction": Transcending Semantics for Clinical Practice.

Authors:  John F Hodes; Carlee I Oakley; James H O'Keefe; Peilin Lu; James E Galvin; Nabeel Saif; Sonia Bellara; Aneela Rahman; Yakir Kaufman; Hollie Hristov; Tarek K Rajji; Anne Marie Fosnacht Morgan; Smita Patel; David A Merrill; Scott Kaiser; Josefina Meléndez-Cabrero; Juan A Melendez; Robert Krikorian; Richard S Isaacson
Journal:  Front Neurol       Date:  2019-01-21       Impact factor: 4.003

Review 5.  N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function.

Authors:  Natalia Soldevila-Domenech; Anna Boronat; Klaus Langohr; Rafael de la Torre
Journal:  Front Nutr       Date:  2019-07-23

6.  Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.

Authors:  Dorothy Keine; John Q Walker; Brian K Kennedy; Marwan N Sabbagh
Journal:  Curr Aging Sci       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.